0 Members and 1 Guest are viewing this topic.
“Speciality vaccine company Valneva has started commercial manufacturing of its promising COVID-19 vaccine candidate in Livingston, West Lothian, Scotland. …If the vaccine proves successful and receives regulatory approval following a rigorous assessment of available data, the Livingston facility will have the capacity to produce up to 250 million doses annually for shipment across the UK and around the world.”